Morphological and Functional Phenotype of Isolated Microvascular Cardiac Allograft Vasculopathy in Heart Transplant Recipients

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The aim of the mCAV study is a comprehensive characterization of the genetic, morphological and functional phenotype of isolated microvascular graft vasculopathy (mCAV) after orthotopic heart transplantation (OHT). The utilized methods include dynamic echocardiography, magnetic resonance imaging, invasive microvascular resistance measurements, histology, cellular calcium-signaling and magnetocardiography as well as molecular genetic expression analysis (miRNA based).

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• able to consent

• Written consent of the participant after clarification and sufficient time to think about participation

• heart transplant recipient

• Indication for routine invasive diagnostics or due to symptoms

• Exercise tolerant in everyday life - cycling, climbing stairs at least 2 floors at a moderate speed without symptoms of exertion or dyspnea

Locations
Other Locations
Germany
DHZC Deutsches Herzzentrum der Charité
RECRUITING
Berlin
Time Frame
Start Date: 2022-10-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 50
Treatments
microvascular cardiac allograft vasculopathy
Heart transplant recipients with microvascular cardiac allograft vasculopathy defined by histopathology and invasive index of microvascular resistance.
control
Heart transplant recipients without microvascular cardiac allograft vasculopathy defined by histopathology and invasive index of microvascular resistance.
Related Therapeutic Areas
Sponsors
Collaborators: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Deutsche Stiftung für Herzforschung
Leads: German Heart Institute

This content was sourced from clinicaltrials.gov